Biospecifics (BSTC) Receives Positive CHMP Opinion for XIAPEX; Aegis Capital Comments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. BLK
6. RKLB
7. AA
8. RSG
9. MRSH
10. RXRX

Go back to Biospecifics (BSTC) Receives Positive CHMP Opinion for XIAPEX; Aegis Capital Comments

Biospecifics Technologies (BSTC) Receives Positive CHMP Opinion for XIAPEX as Peyronie's Disease Treatment

December 22, 2014 4:09 PM EST

Biospecifics Technologies (NASDAQ: BSTC) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the use of XIAPEX for the treatment of adult men with Peyronie's disease with a palpable plaque and a curvature deformity of at least 30 degrees... More